Credit ACIP/CDC
#15,927
Last Friday the CDC & FDA Lifted The Pause On J&J COVID Vaccine Following A Safety Review, and later today the CDC will hold a COCA (Clinicians Outreach Communications Activity) call to present the latest information on TTS (Thrombosis with Thrombocytopenia) after administration of the J&J/Janssen COVID-19 vaccine.
These COCA webinars are often technical, and are of greatest interest to clinicians and healthcare providers, but also may be of interest to the general public.
As always, If you are unable to attend the live presentation, these (and past) webinars are archived and available for later viewing at this LINK. Details on today's presentation follow:
Johnson & Johnson/Janssen COVID-19 Vaccine and Thrombosis with Thrombocytopenia Syndrome (TTS): Update for Clinicians
Overview
This COCA Call will present the latest evidence on thrombosis with thrombocytopenia syndrome (TTS) after administration of the Johnson & Johnson/Janssen COVID-19 vaccine. Speakers will discuss information on TTS and updated vaccine recommendations.
Presenters
Sara Oliver, MD, MSPH
LCDR, U.S. Public Health Service
Co-lead, Advisory Committee for Immunization Practices COVID-19 Vaccines Work Group
COVID-19 Response
Centers for Disease Control and Prevention
Tom Shimabukuro, MD, MPH, MBA
CAPT, U.S. Public Health Service
Vaccine Safety Team Lead
COVID-19 Response
Centers for Disease Control and Prevention
Call Materials
None at this moment
Call Details
When:
Tuesday, April 27, 2021,
2:00 PM – 3:00 PM ET
Webinar Link:
https://www.zoomgov.com/j/1601111927?pwd=UTliM1BEWnJ0SkpKUzZnZUVDTVBxUT09external icon
Passcode: 358595
Dial In:
US:+1 669 254 5252
or +1 646 828 7666
or +1 551 285 1373
or +1 669 216 1590
International numbersexternal icon
One tap mobile :
US: +16692545252,,1601111927#,,,,*358595# or +16468287666,,1601111927#,,,,*358595#
Webinar ID: 160 111 1927
